Cargando…
Recurrent Body Rash Warranted Second Desensitization With Acyclovir in a Myeloma Patient: A Case Report
A 75-year-old woman developed a moderately severe rash about a week and a half after the start of bortezomib (Btb)-based chemotherapy for IgG lambda multiple myeloma; at the time, she was also receiving acyclovir as antiviral prophylaxis in addition to herpes zoster (HZ) vaccination. HZ reactivation...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elmer Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505310/ https://www.ncbi.nlm.nih.gov/pubmed/28725322 http://dx.doi.org/10.14740/jocmr2772w |